Number of Shares
3.13 Mil
Current Holdings Value*
$49.67 Mil
% of Portfolio
12.76%
Total Estimate Gain
$-3.31 Mil
% of Total Estimate Gain
-7.24%

SR ONE CAPITAL MANAGEMENT, LP's Mineralys Therapeutics Inc Holding Summary

As of 2025-03-31, SR ONE CAPITAL MANAGEMENT, LP held 3.13 Mil shares of Mineralys Therapeutics Inc(MLYS), totaling $49.67 Mil. This investment constitutes 12.76% of their stock portfolio, and SR ONE CAPITAL MANAGEMENT, LP now holds 4.82% of the outstanding Mineralys Therapeutics Inc(MLYS) stock.

The initial trade took place in 2023Q1. And since then SR ONE CAPITAL MANAGEMENT, LP has made 3 purchases of MLYS, at an average price of $14.62, for a total of 3.13 Mil shares. Based on historical transaction data and MLYS's current price of $13.56, SR ONE CAPITAL MANAGEMENT, LP's estimated gain on his MLYS holdings is $-3.31 Mil, reflecting a -7.24% gain to date.

SR ONE CAPITAL MANAGEMENT, LP MLYS ($13.56) Holding Chart

SR ONE CAPITAL MANAGEMENT, LP MLYS ($13.56) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1